Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on Benzinga about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients.
